← Leaderboards
Nancy Weijiun Lin
National Jewish Health
$621,533
Attributed
$621,533
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $256.8K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$621,533 · 1
By mechanism
K23$621,533 · 1
Top collaborators
No co-investigators on record.
Most similar at National Jewish Health
Same institution · by research overlap
- Lisa A Maier$11,952,941
- Donna L Bratton$11,834,515
- Nabeel Hamzeh$3,068,174
- Ivana V Yang$13,155,768
- Sonia Leach$1,607,855
Others in their field
Other Rising Stars on “Environmental Exposure”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Dawn Fallacara · Battelle Centers/Pub Hlth Res & Evaluatn$18,486,286
- Christine W Hockett · Avera Mckennan$8,908,366
- Hill Georgette · Integrated Laboratory Systems, Llc$8,700,000
- Cathryn Peltz · Henry Ford Health + Michigan State University Health Sciences$7,977,678
- Hong-Ngoc B. Nguyen · University Of Minnesota$6,812,121
Research focus
Environmental ExposureAccurate DiagnosticsEnvironmentBiopsyBronchoalveolar LavageBiological MarkersBiomarker DevelopmentAffectCellsCharacteristicsClinical CareClinical HeterogeneityClinical ManagementCohortCohort StudiesComplexCause Of DeathDiagnosisDiagnostic BiomarkerDiagnostic SensitivityDifferential ExpressionDisease ProgressionDisorder ControlEpigenetic Process
Grant awards (4)
MicroRNA as Diagnostic and Prognostic Biomarkers in Sarcoidosis$182,165
K23 · FY2025 · HL · contact PI
MicroRNA as Diagnostic and Prognostic Biomarkers in Sarcoidosis$74,670
K23 · FY2025 · HL · contact PI
MicroRNA as Diagnostic and Prognostic Biomarkers in Sarcoidosis$182,165
K23 · FY2024 · HL · contact PI
MicroRNA as Diagnostic and Prognostic Biomarkers in Sarcoidosis$182,533
K23 · FY2023 · HL · contact PI